ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.38
0.12%
US Tech 100
21,219.60
1.08%
S&P 500
6,086.37
0.61%
US Dollar vs CAD
1.43888
-0.04%
Bitcoin
103,012.55
-0.60%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Calliditas Therapeutics AB (CALT)

  7. Calliditas Therapeutics AB (CALT) News

CALT

Calliditas Therapeutics AB (CALT)

Calliditas Therapeutics AB
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CALT
DateTimeSourceHeadlineSymbolCompany
09/23/20243:44PMEdgar (US Regulatory)Form 15F-12B - Securities registration termination of foreign private issuers [Section 12(b)]NASDAQ:CALTCalliditas Therapeutics AB
09/16/20248:46AMPR Newswire (US)Delisting of Calliditas Therapeutics AB (publ) from Nasdaq StockholmNASDAQ:CALTCalliditas Therapeutics AB
09/03/20246:13AMPR Newswire (US)Notice of extraordinary meeting of Calliditas Therapeutics AB (publ)NASDAQ:CALTCalliditas Therapeutics AB
09/03/20245:33AMPR Newswire (US)Calliditas Therapeutics takes certain corporate actions following announcement by Asahi KaseiNASDAQ:CALTCalliditas Therapeutics AB
09/03/20245:31AMPR Newswire (US)Calliditas Therapeutics takes certain corporate actions following announcement by Asahi KaseiNASDAQ:CALTCalliditas Therapeutics AB
08/13/202412:25AMPR Newswire (US)Calliditas Interim Report January to June 2024NASDAQ:CALTCalliditas Therapeutics AB
08/13/202412:22AMPR Newswire (US)Calliditas Interim Report January to June 2024NASDAQ:CALTCalliditas Therapeutics AB
08/05/202412:26AMPR Newswire (US)Invitation to the presentation of Calliditas´s interim report January - June 2024NASDAQ:CALTCalliditas Therapeutics AB
08/05/202412:19AMPR Newswire (US)Invitation to the presentation of Calliditas´s interim report January - June 2024NASDAQ:CALTCalliditas Therapeutics AB
08/01/20248:00AMGlobeNewswire Inc.Calliditas Therapeutics to Attend 2024 Women in Nephrology (WIN) Leadership ConferenceNASDAQ:CALTCalliditas Therapeutics AB
07/31/20247:23AMPR Newswire (US)Number of shares and votes in Calliditas TherapeuticsNASDAQ:CALTCalliditas Therapeutics AB
07/26/20243:05PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CALTCalliditas Therapeutics AB
07/26/202410:23AMPR Newswire (US)Calliditas partner STADA receives European Commission decision for full approval of Kinpeygo® for the treatment of IgA NephropathyNASDAQ:CALTCalliditas Therapeutics AB
07/26/202410:21AMPR Newswire (US)Calliditas partner STADA receives European Commission decision for full approval of Kinpeygo® for the treatment of IgA NephropathyNASDAQ:CALTCalliditas Therapeutics AB
07/26/20241:29AMPR Newswire (US)Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitisNASDAQ:CALTCalliditas Therapeutics AB
07/26/20241:23AMPR Newswire (US)Calliditas announces positive TRANSFORM Phase 2b topline data in primary biliary cholangitisNASDAQ:CALTCalliditas Therapeutics AB
07/04/20242:44AMPR Newswire (US)Launch of Phase 3 clinical trial with Nefecon in JapanNASDAQ:CALTCalliditas Therapeutics AB
07/04/20242:20AMPR Newswire (US)Launch of Phase 3 clinical trial with Nefecon in JapanNASDAQ:CALTCalliditas Therapeutics AB
06/18/20245:25AMPR Newswire (US)Calliditas provides setanaxib patent updateNASDAQ:CALTCalliditas Therapeutics AB
06/18/20245:23AMPR Newswire (US)Calliditas provides setanaxib patent updateNASDAQ:CALTCalliditas Therapeutics AB
06/17/202411:01AMPR Newswire (US)Bulletin from the annual general meeting of Calliditas Therapeutics AB (publ)NASDAQ:CALTCalliditas Therapeutics AB
05/30/20243:52PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CALTCalliditas Therapeutics AB
05/30/20241:20PMPR Newswire (US)Calliditas partner STADA receives positive CHMP opinion recommending full approval for Kinpeygo® for the treatment of IgA nephropathyNASDAQ:CALTCalliditas Therapeutics AB
05/30/20241:18PMPR Newswire (US)Calliditas partner STADA receives positive CHMP opinion recommending full approval for Kinpeygo® for the treatment of IgA nephropathyNASDAQ:CALTCalliditas Therapeutics AB
05/28/20247:46AMPR Newswire (US)Calliditas Therapeutics Presents Data at the 61st European Renal Association CongressNASDAQ:CALTCalliditas Therapeutics AB
05/28/20247:36AMPR Newswire (US)Calliditas Therapeutics Presents Data at the 61st European Renal Association CongressNASDAQ:CALTCalliditas Therapeutics AB
05/28/20247:28AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CALTCalliditas Therapeutics AB
05/28/20247:09AMEdgar (US Regulatory)Form SC14D9C - Written communication relating to third party tender offerNASDAQ:CALTCalliditas Therapeutics AB
05/28/20242:17AMPR Newswire (US)Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei CorporationNASDAQ:CALTCalliditas Therapeutics AB
05/28/20242:14AMPR Newswire (US)Statement by the Board of Directors of Calliditas Therapeutics AB (publ) in relation to the public offer by Asahi Kasei CorporationNASDAQ:CALTCalliditas Therapeutics AB
 Showing the most relevant articles for your search:NASDAQ:CALT

Your Recent History

USOTC
ASII
Accredited Solutions (PK)
USOTC
CLHI
CLST (PK)
USOTC
BMXI
Brookmount Explorations (PK)
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
COIN
SHIBUSD
SHIBA INU
NASDAQ
TNXP
Tonix Pharmaceuticals
USOTC
UMAV
UAV Corpoation (PK)
NASDAQ
FCEL
FuelCell Energy
USOTC
WDLF
Decentral Life (PK)
USOTC
HIRU
Hiru (PK)
USOTC
AXXA
Exxe (PK)
USOTC
XERI
Xeriant (QB)
USOTC
RSPI
RespireRx Pharmaceuticals (CE)
USOTC
AABB
Asia Broadband (PK)
USOTC
BIEL
Bioelectronics (PK)
USOTC
RDGL
Vivos (QB)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads